Page 1 of Clinical Trials for Drug Alemtuzumab, 270 Total Matches
- 1Not yet recruitingLast Updated: April 19, 2006Condition(s): Pancreas-Kidney Transplantation
- 2TerminatedLast Updated: May 9, 2012Condition(s): Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell
- 3RecruitingLast Updated: October 10, 2008Condition(s): Organ Transplantation
- 4CompletedEffectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted KidneysLast Updated: September 13, 2010Condition(s): Graft Rejection; Kidney Disease
- 5CompletedLast Updated: August 9, 2011Condition(s): Kidney Transplantation
- 6Active, not recruitingLast Updated: July 15, 2011Condition(s): Myelodysplastic and Myeloproliferative Disorders; Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Multiple Myeloma; Plasma Cell Dyscrasia; Lymphoproliferative Disorders; Hematologic Diseases
- 7CompletedLast Updated: December 21, 2010Condition(s): Immunologic Deficiency Syndrome
- 8RecruitingLast Updated: June 27, 2011Condition(s): End-stage Renal Failure; Graft Rejection
- 9CompletedLast Updated: December 2, 2009Condition(s): Hematologic Malignancy
- 10Active, not recruitingLast Updated: August 5, 2011Condition(s): Evidence of Liver Transplantation; Rejection; ALEMTUZUMAB/NATALIZUMAB [VA Drug Interaction]
- 11Active, not recruitingLast Updated: February 6, 2009Condition(s): Kidney Cancer
- 12RecruitingLast Updated: April 10, 2012Condition(s): Leukemia; Hodgkin Lymphoma; Non Hodgkin Lymphoma; Myeloproliferative Disorders
- 13RecruitingLast Updated: April 11, 2012Condition(s): Hematologic Malignancies
- 14WithdrawnLast Updated: December 28, 2011Condition(s): Chronic Lymphocytic Leukaemia; Patients Resistant to a Purine Analogous; Patients Relapsed With Purines Therapy
- 15RecruitingLast Updated: May 12, 2012Condition(s): Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma
- 16RecruitingLast Updated: June 2, 2011Condition(s): Metabolic Disorders; Hematologic, Immune, or Bone Marrow Disorders; Hemoglobinopathies
- 17Active, not recruitingLast Updated: January 10, 2011Condition(s): Graft Rejection
- 18TerminatedLast Updated: August 18, 2009Condition(s): Acute Rejection; Renal Transplantation
- 19RecruitingLast Updated: March 20, 2012Condition(s): Peripheral Blood Stem Cell Transplantation; Anemia, Sickle Cell; Graft-Versus-Host Disease; Sirolimus (Rapamune(Registered Trademark)); Alemtuzumab (Campath(Registered Trademark))
- 20RecruitingLast Updated: December 2, 2011Condition(s): CLL; SLL
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Alemtuzumab
